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INVITED REVIEW

Visual Mapping With Magnetoencephalography: An Update on the
Current State of Clinical Research and Practice With Considerations
for Clinical Practice Guidelines
Andrew Zillgitt,* Gregory L. Barkley,* and Susan M. Bowyer*†‡
Department of Neurology, Henry Ford Health System, Detroit, Michigan, U.S.A.; †Department of Neurology, Wayne State University, Detroit, Michigan, U.S.A.;
and ‡Department of Physics, Oakland University, Rochester, Michigan, U.S.A.
*

Summary: Using visual evoked ﬁelds (VEFs) to differentiate
healthy, normal brain function from dysfunctional cortex has
been demonstrated to be both valid and reliable. Currently, VEFs
are widely implemented to guide intracranial surgeries for
epilepsy and brain tumors. There are several areas of possible
future clinical use of VEFs, including early identiﬁcation of
disorders, such as multiple sclerosis, Parkinson’s disease, stroke,
and human immunodeﬁciency virus–associated neurocognitive
disorders. These studies have suggested that VEFs could be used

isual evoked ﬁelds (VEFs) have been reliably used in
clinical practice since the late 1990s. This is a standard
clinical tool for tailoring a surgical resection in the occipital
cortex.1 In 2011, the American Clinical Magnetoencephalography Society (ACMEGS) published clinical practice guidelines (CPGs) detailing the analysis of spontaneous cerebral
activity, presurgical functional brain mapping using evoked
ﬁelds, magnetoencephalography (MEG) reporting, and the
qualiﬁcations of MEG personnel.2–5 Even more recently, the
ACMEGS published a second position statement speciﬁcally
detailing the value of MEG as a noninvasive diagnostic tool in
the presurgical mapping of eloquent cortices and supported,
“The routine clinical use of MEG in obtaining noninvasive
localizing or lateralizing information regarding eloquent
cortices (somatosensory, motor, visual, auditory, and language)
in the presurgical evaluation of patients with operable lesions
preparing for surgery.”6
Although the “gold standard” for mapping eloquent
cortices has been through direct cortical stimulation, MEG as
a noninvasive diagnostic tool has established its effectiveness in
identifying these regions.1–3,6 This article will focus on utility
of MEG in localizing eloquent visual cortex. It will begin by
providing an overview of the current clinical role of VEFs in
clinical practice. After this, an update of research and clinical
developments that have followed the publication of the
ACMEGS CPGs in 2011 will be reviewed. Finally,
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to study disease pathophysiology or as a biomarker for early
identiﬁcation of a disorder. The current clinical practice guidelines of the American Clinical Magnetoencephalography Society
for VEFs are sufﬁcient. At this time, VEFs should be used clinically
to identify visual cortex and potentially tailor surgical resections.
Key Words: Magnetoencephalography, Magnetic evoked ﬁelds,
Visual evoked ﬁelds, Visual processing, Presurgical mapping.
(J Clin Neurophysiol 2020;37: 585–591)

recommendations for clinical practice, based on previous
studies and current research, will be outlined.

CURRENT CLINICAL ROLE OF MEG IN
VISUAL MAPPING
Magnetoencephalography is a noninvasive methodology
that directly measures neuronal signaling by recording the
magnetic ﬁeld created from dendritic, intracellular, electrical
currents of the neuron at the surface of the head.1–3,6–10 In EEG,
the different conductivities of brain, cerebrospinal ﬂuid, skull,
and scalp lead to smearing of potential distribution on the scalp
and therefore compromised localization accuracy. In contrast,
magnetic ﬁelds are not signiﬁcantly distorted by biologic tissues,
which allows for superior spatial resolution of MEG compared
with EEG. Finally, MEG exhibits a distinct sensitivity to
tangential sources arising from sulci.8,10 This is extremely useful
in localizing primary visual cortex, as the triangular shape of the
occipital lobe is composed of numerous sulci.11 The clinically
most accepted and used MEG source model is the single
equivalent current dipole (ECD).1–3,6–10 With the implementation
of various acceptance parameters (e.g., conﬁdence volume and
goodness of ﬁt),12 the single ECD result is displayed on the
patient’s structural MRI, revealing the estimated source localization (thus called, magnetic source imaging).
Between 1968 and 1972, David Cohen demonstrated the
ability to noninvasively measure and analyze magnetic ﬁelds
produced from electrical currents of synchronous neuronal activity.13,14 Throughout the 1980s and 1990s, many basic science VEF
articles were published that supported the use of MEG to detect
visual processing. These research studies are not included here
because this article is limited to clinical studies that used VEF.
In this regard, Brenner published the ﬁrst documented VEF
study in 1975.15 In three subjects, a reproducible response
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(P100m) was obtained 5 to 8 cm above the inion, and the authors
concluded these results were, “. clearly localized in the vicinity
of the visual areas of the brain”.3 After this, in 1991, Harding
et al.18 described topographic localization of the P100m response
using half ﬁeld and full ﬁeld stimulation in four subjects. Then, in
1996, Nakasato et al.16 outlined the clinical application of VEFs
with coregistration of the VEF dipoles to a structural brain MRI. A
robust P100m response was present in all healthy subjects, and this
differed from four individuals with bitemporal hemianopsia and
ﬁve people with occipital lobe lesions and hemianopsia. In the
latter cases, only a P100m response was present in the unaffected
occipital lobe.16 A second VEF study in 1996 evaluated P100m
response in ﬁve healthy subjects and revealed dipole localization
within the bottom of the calcarine ﬁssure.17 In 1998 Ikeda et al.19
demonstrated a VEF consisting of a large deﬂection with a latency
of 100 to 120 milliseconds (P100m) that localized around the
calcarine ﬁssure. Finally, in 1998, the origin of the N75m, P100m,
and N145m was studied in six healthy young adults.20 The
reliability of the dipole estimation was highest for the P100m
response, and this dipole mapped to the calcarine ﬁssure.
Furthermore, the results were in agreement with the retinotopic
organization in humans that was described by Holmes in 1945.20
The authors concluded, “The presence of the retinotopic organization of the P100m thus suggests that its generator may be located
in the cortex around the calcarine ﬁssure.”20
These studies have provided evidence that VEFs yield
consistent results across different neuromagnetism laboratories,
indicating reliability and external validity.3,16–20 As detailed
below, other studies have demonstrated internal validity in so far
as occipital lobe lesions abolish or displace VEFs.16,22 In a case
study from 2004, VEFs were evaluated in conjunction with
visually evoked potentials and electrocorticography.21 The
authors explained the differences between electrocorticography
and MEG modalities, speciﬁcally outlining the differences in
sensitivity to neuronal sources (e.g., sulcal compared with gyral
sources) and spatial resolution. In this report, the authors stated,
“. the magnetic ﬁeld distribution for the VEF response clearly
demonstrates the accuracy of the direction of the ECD.”
Moreover, by integrating electrocorticography, visually evoked
potential, and VEF, the visual motion complex was accurately
mapped.21 Taken together, the reproducibility of VEFs and
single ECD localization across different centers in conjunction
with abolishment or displacement of VEFs in occipital cortex
lesions and concordant results between VEFs and electrocorticography suggests that VEFs are both reliable and valid
measurements of eloquent visual cortex.3,16–21
As the technique for acquiring VEFs became reﬁned, many
MEG centers have found it relatively easy to acquire, analyze, and
report VEFs. Figs. 1A–1F illustrates normal VEFs in a 19-year-old
right-handed young man with drug-resistant focal epilepsy
undergoing an epilepsy presurgical evaluation. For a review of
the minimum requirements for VEFs, please refer to Table 1.

AN UPDATE ON CLINICAL RESEARCH WITH VEFs
As detailed above, several studies have demonstrated VEFs
yield reasonable, and consistent, results with the P100m
586
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localization within the calcarine ﬁssure. Using VEFs to differentiate healthy, normal brain function from dysfunctional cortex was
ﬁrst documented by Nakasato et al.16 when healthy subjects and
individuals with pituitary adenomas compressing the optic chiasm
and structural occipital lobe lesions were studied. The ability to
differentiate normal and abnormal cortical function has been
widely implemented to guide intracranial surgeries.
Our MEG center published one of the early series demonstrating the utility of VEFs in tailoring surgical resections.
Grover et al.22 reported a case series of 21 patients with
temporoparieto-occipital lesions where VEFs guided the resection strategy. In this study, a black and white hemiﬁeld
checkerboard pattern reversed at 1 Hz. A single ECD model
was used to locate the VEF locations on the patient’s brain MRI.
In this series, 15 of 21 patients exhibited preoperative visual ﬁeld
deﬁcits, and the VEFs altered the surgical treatment plan in 3
cases. In 1 case (patient #15), the patient had a complete
homonymous hemianopsia, and the surgery was changed from
a complete resection of the tumor, cyst, and margins to a limited
resection of the tumor only. The VEFs indicated that the occipital
cortex could detect the visual stimuli, even though the subject
was unable to see the reversing pattern. All VEF latencies were
delayed (the N75m had a latency of 155 milliseconds, the P100m
had a latency of 189 milliseconds, and the N145m had latency of
242 milliseconds). The P100m was located just mesial to the wall
of the cystic lesion in the right occipital lobe. The N145m was
also along the mesial wall of the cystic lesion. Following this
tailored resection, the patient experienced near total resolution of
the hemianopsia22 (Figs. 2A and 2B and Figs. 3A–3C).
Similar results were illustrated by Pang et al.23 in 2014 in
a series of case studies with 12 children using large check size,
high-contrast, black-and-white, checkerboard pattern that reversed
at 2 Hz. Using a single ECD model, the sources of VEFs were
displayed on the patient’s brain MRI. The VEF did not
demonstrate signiﬁcant differences in regard to the P100m latency
or dipole moment. However, in the affected/lesional occipital
lobe, there was a lateral shift in the dipole localization. The
authors concluded that this was most likely due to mass effect
from the lesion and also noted, “. function can be preserved
when functional cortex is shifted, but not when it’s damaged.” In
addition, they concluded, “This demonstrates the added value of
MEG recordings as a tool in the neurologic examination.”23
In this regard, Pang et al.23 expanded the potential utilization
of VEFs. Speciﬁcally, VEFs could be completed as a screening
test to evaluate mass effect of lesions within functional cortex. At
times, acquiring brain MRI in children can be challenging, while
MEG is often a child-friendly technology. By quickly identifying
VEFs that are abnormal, a patient’s brain MRI could then be
expedited if needed.
In another study, MEG and magnetic resonance axonography were used to reduce the risk of neurologic deﬁcits in
patients undergoing stereotactic irradiation. Overall, approximately 70% of the treatment plans were modiﬁed using these
techniques. The authors concluded that the integration of evoked
ﬁelds, including VEFs, and magnetic resonance axonography
could limit functional complications from radiation therapy.24
Similarly, the use of three-dimensional anisotropy MRI
and VEF were described in a case report from 2004. 25 These
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FIG. 1. A–F, Normal VEFs. The patient is a 19 year-old right-handed young man with drug-resistant focal epilepsy. His seizures would often
consist of a visual disturbance without a loss of awareness. Video-EEG monitoring revealed seizures arising from the bilateral occipital lobes,
and MEG demonstrated a source at the junction of the right superior parietal lobule and occipital cortex. A–C, The VEF for left hemiﬁeld
stimulation, including the P100m peak (A), contour plot (B), and single ECD localization (C). D–F, Results of right hemiﬁeld stimulation with
the P100m peak (D), contour plot (E), and single ECD (F). AXE, axial; ECD, equivalent current dipole; LVF, left visual ﬁeld; MEG,
magnetoencephalography; RVF, right visual ﬁeld; SAG, sagittal; VEF, visual evoked ﬁelds; VFR, coronal plane.

techniques were used preoperatively to accurately localize
optic radiations and primary visual cortex in a patient with an
occipital lobe tumor. There was complete resection of the
tumor with no visual ﬁled deﬁcits before or after the
surgery.25 Therefore, the combination of VEFs with tractography can be valuable not only in limiting injury to functional
cortex but also in potentially reducing damage to white
matter pathways.
clinicalneurophys.com

The utility of VEFs in identifying visual cortex has been well
established, and CPGs have detailed the minimum requirements for
acquiring, analyzing, and reporting VEFs.3,6 In addition, several
studies have documented the utility of VEFs in differentiating normal
and abnormal visual cortex, tailoring surgical resections, and as
a possible screening tool for other diagnostic testing.16,22–25
However, in clinical practice, the use of VEFs is relatively
uncommon.26 In a survey of clinical MEG centers in the United
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ACMEGS Clinical Practice Guidelines for VEF3

Indications
Localization of primary visual cortex before neurosurgical resections.
Assessment of abnormal visual function.
Stimulation
Typically generated using specialized presentation computer with image shown on a back-projection screen
To eliminate partial visual ﬁeld effects, projectors must be chosen that can reduce the projected image.
To eliminate time errors or jitter, a timing synch pulse that is accurate to within 1 ms can be recorded by the MEG system to determine if the stimulus trigger
pulse was accurately recorded.
To assess the visual system, full-ﬁeld, hemiﬁeld, and/or quadrant steady-state stimuli may be used; contrast, luminance, screen placement, check size, and ﬁeld
size to produce appropriate subtended visual angle should follow the parameters used for conventional scalp visual evoked potential guidelines.
Half-ﬁeld checkerboard reversal pattern with 1-s ISI is the most common procedure.
A ﬁxation point should be provided. If the patient cannot ﬁxate well, full-ﬁeld stimulation should be used.
Adequate sleep of the patient before VEF testing is essential.
Data acquisition
Band pass of 0.03–300 Hz with a digitization rate of at least 1,000 Hz is preferred to facilitate postprocessing of the raw data.
Recording the raw data is mandatory to permit discarding undesirable trials or channels post hoc.
Real-time averaging is optional and may help to determine the number of necessary trials; 200–500 trials may be required to yield an adequate number of
acceptable trials. Averaging off-line after data collection permits noise reduction processing and manual or automatic artifact rejection.
Epoch duration of 2100 to 300 ms.
Stimulus channel indicators should be present and clearly labeled in the raw data to indicate stimulation triggers.
Jitter should be less than 50 microseconds.
Head position measurement should be carried out before each ensemble or data block. Use of continuous head position tracking is preferred if available.
The testing paradigm should be repeated to assess reproducibility and ensure consistent results.
Optional real-time averaging can be helpful to obtain an estimate of the SNR.
Data analysis
Recording of raw data should be mandatory and analysis system must permit post hoc averaging.
The analysis system must permit inspection of raw data.
Off-line averaging after data acquisition permits:
Noise reduction processing;
Elimination of artifact-containing traces;
Judicious selection of band-pass ﬁltering (typical high pass cutoff from 1 to 9 Hz and low pass cutoff from 50 to 100 Hz).
Include sufﬁcient trials to obtain a robust response, typically 100–200 artifact free epochs.
Source localization
During source analysis computations, the location of the P100m should be identiﬁed.
Ensemble replications should differ from each other by less than 5 mm for the localization of the P100m.
ACMEGS, American Clinical Magnetoencephalography Society; ISI, inter-stimulus interval; MEG, magnetoencephalography; SNR, signal-to-noise ratio; ms, milliseconds; VEF,
visual evoked ﬁelds.

States, only 62 VEF studies were completed across 15 centers from
2006 to 2007.26 The reasons behind the low use of VEFs in clinical
practice are not well understood, but it could be related to a relatively
low prevalence of epilepsy and tumors in the occipital cortex.

NEW CLINICAL VEF APPLICATIONS
Clinically pertinent VEF studies that would affect clinical
decision making are limited. However, presently, several VEF
studies are exploring the utility of VEF in various disease states.
This is in line with the ACMEGS second position statement that
advocated for “further systemic clinical research that seeks to
establish other clinical indications for MEG.”6 Although the
impact of these studies on clinical decision making has not been
completely elucidated, these studies have shown promise in
identifying various brain functions and classifying and characterizing different disease states.
For example, a recent study evaluated the peak latency of
the ﬁrst four components of VEFs in people with idiopathic
588

Parkinson’s disease (IPD) compared with healthy controls. The
N75m and P100m components were signiﬁcantly greater with the
N75m-component latency markedly increased in people with
IPD compared with healthy controls. Additionally, the N75m
latency positively correlated with the Uniﬁed Parkinson’s
Disease Rating Scale score, indicating a greater disease burden.
The authors also suggested that these results were induced by
retinal damage and noted that the underlying pathophysiology of
IPD may develop in conjunction with visual dysfunction in the
early stages of IPD.27 Therefore, the VEF abnormalities could be
an independent marker of disease state and/or disease progression.
In another study, a single ECD was used to analyze VEFs in
subjects with unilateral spatial neglect (USN) from a stroke. The
presence or absence of the P100m and N145m after hemiﬁeld
stimulation was determined. All three patients exhibited left
USN, and the study demonstrated that early VEFs are disrupted.
It also supported the hypothesis that visual processing deﬁcits are
different based on the clinical subtype of USN and the location of
the lesion. For example, one patient in this study (patient 1) had
an absent N145m response and a parietal lobe lesion, while
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FIG. 2. A and B, VEFs in a patient with a right occipital mass. The
patient is a 51-year-old man with a right occipital cystic mass and
enhancing mural nodule. On examination and Goldmann perimetry,
there was a left homonymous hemianopsia. A, VEF waveforms from
left hemiﬁeld stimulation (affected hemisphere), while (B)
demonstrates normal waveforms (N75m, P100m and N145m)
following right hemiﬁeld stimulation. Please note the scale bar
should correspond to 50 fT, not 50 pT as labeled. VEF, visual evoked
ﬁelds.

another patient (patient 2) had USN but a lesion extending to the
temporoparietal junction with an absent P100m response. The
authors suggested the possibility of using VEFs to study subtypes
of neglect.28
Visual evoked ﬁelds were also studied in human immunodeﬁciency virus (HIV)–associated neurocognitive disorders
and multiple sclerosis (MS).29,30 In 2013, Wilson et al.29
evaluated visual processing in individuals with HIV. In this
study, subjects viewed a small checkerboard pattern in the top
right visual quadrant. In place of a single ECD, beamformer
technique was used and results coregistered to the patient’s
brain MRI. Control subjects without HIV exhibited increased
neuronal synchronization in the theta and alpha frequency
bands within the right dorsolateral prefrontal cortex, right
frontal eye ﬁelds, and posterior cingulate. In contrast, HIVinfected participants displayed reduced synchrony in these
regions, and furthermore, the magnitude of these decreases in
many cortical association regions was correlated to the
clinicalneurophys.com

neuropsychologic performance. The study concluded, “MEGbased imaging holds potential as a noninvasive biomarker for
HIV-related neuronal dysfunction ..”
Barratt et al.30 used beamformer to analyze visuomotor
responses in patients with MS. Beamformer is a spatial ﬁltering
technique that differs from the single ECD. This technique uses
the MEG sensors and combines the signals recorded at each
region in the brain to increase the signal-to-noise ratio (e.g.,
resolution). This technique then scans the entire brain region to
ﬁnd the active neural regions. In this study, time-to-peak
postmovement beta rebound (a phenomenon associated with
long-range connectivity of sensorimotor systems) during cognitive tasks (symbolic digit modalities test) was signiﬁcantly
increased in people with MS when compared with healthy
controls. This result has clinical signiﬁcance in that reduction in
information processing speed is the most commonly affected
cognitive domain in MS.30 Although the methodology in this
study differs from that in IPD (detailed above), the results
suggest using visual tasks as a biomarker for disease progression
in both IPD and MS. Speciﬁcally, in regard to MS, measuring
the postmovement beta rebound may serve as a biomarker for
cognition in people with MS.
Steady-state visually evoked ﬁelds were examined in
processing positive and negative impression images. This study
used the International Affective Picture System, which is used to
examine emotional processes. A total of 200 images were
categorized as “negative,” “positive,” and “neutral” according
to the categorization in each subject. The location of the sources
was within the same area in the occipital lobe. However, the
amplitude of steady-state visually evoked ﬁeld source was larger
for “negative” impression images compared with “positive”
impression images. The authors concluded that the emotional
object modulated the steady-state visually evoked ﬁeld amplitude. Furthermore, steady-state visually evoked ﬁeld could be
a measure of emotion.31
Visual images have frequently been used in MEG to
evaluate cognitive function in healthy subjects, and repeated
visual presentations may be used to collect data regarding
underlying functional brain networks. For example, in a recent
study of visuospatial attention, the investigators identiﬁed
frequencies and anatomic networks in phase synchronization
using source localized MEG data. Their results demonstrated that
visuospatial attention was associated with long-range synchronization of high-alpha activity (10–14 Hz) within the frontal,
parietal, and occipital regions. Additionally, stronger high-alpha
phase synchronization was associated with decreased reaction
times to attended stimuli.32 Although this study did not use VEFs
in the strictest sense, it may provide an opportunity to use VEFs
in research and eventually clinical practice as a tool for
measuring attention and other cognitive functions.
The implementation of these results into current clinical
practice remains to be determined. However, they have provided
insight in regard to normal brain functions (e.g., emotions) and
the pathophysiology of various diseases from IPD to USN
following stroke to HIV-associated neurocognitive disorders
and MS.27–32 The expansion of evoked ﬁelds, speciﬁcally VEFs,
into other disease states may provide new clinical indications for
VEFs outside of surgical planning.
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RAMIFICATIONS AND RECOMMENDATIONS FOR
CLINICAL PRACTICE
With the creation of the ACMEGS CPGs in 2011, the
acquisition and analysis of spontaneous cerebral activity and
evoked ﬁelds was standardized. Although not regularly used in
clinical practice, the utility of VEFs in identifying visual cortex
has been well recognized, and several studies have documented
the ability of VEFs to differentiate normal and abnormal visual
cortex and tailor surgical resections.15–25 As described in previous
paragraphs, more recent studies have suggested that VEFs could
be used as a screening tool in assessing the need for more
expedited structural brain imaging (brain MRI).23 Other VEF
studies have explored their utility in various disease states.27–32
These studies have suggested that VEFs could be used to study
disease pathophysiology (e.g., IPD) or as a biomarker in
conditions such as HIV-associated neurocognitive disorders.27,29
These clinical research studies provide support for future clinical
applications of MEG and speciﬁcally VEFs.

CONCLUSIONS
Therefore, at this time, there is evidence that supports the
current CPGs outlined by the ACMEGS in 2011. Continued
research using VEFs outside of presurgical mapping of visual
cortex may lead to new VEF clinical indications. If these
techniques can be validated and standardized for speciﬁc diseases
(e.g., HIV-associated neurocognitive disorders and MS), their
inclusion in new clinical practice guidelines would be warranted.
However, presently, the current CPGs for VEFs are sufﬁcient,
and VEFs should be used clinically to identify visual cortex and
potentially tailor surgical resections.
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stimulation is denoted with yellow circles. Coronal slice (A): 1.3 cm;
axial slice (B): 4.6 cm; sagittal slice (C): 1.5 cm. These results
changed surgical planning from complete resection of tumor, cyst,
and margins to tailored resection of the tumor only. Following
surgery, his left homonymous hemianopsia improved immediately.
VEF, visual evoked ﬁelds.
590

1. Bagic A, Funke ME, Ebersole J. American Clinical MEG Society
(ACMEGS) Position Statement: the value of magnetoencephalography
(MEG)/magnetic source imaging (MSI) in the noninvasive presurgical
evaluation of patients with medically intractable localization-related
epilepsy. J Clin Neurophysiol 2009;26:290–293.
2. Bagic AI, Knowlton RC, Rose DF, Ebeersole JS. American Clinical
Magnetoencephalography Society Clinical Practice Guideline 1: recording and analysis of spontaneous cerebral activity. J Clin Neurophysiol
2011;28:348–354.
3. Burgess RC, Funke ME, Bowyer SM, Lewine JD, Kirsch HE, Bagic AI.
American Clinical Magnetoencephalography Society Clinical Practice
Guideline 2: presurgical functional brain mapping using magnetic
evoked ﬁelds. J Clin Neurophysiol 2011;28:355–361.
4. Bagic AI, Knowlton RC, Rose DF, Ebersole JS. American Clinical
Magnetoencephalography Society Clinical Practice Guideline 3: MEGEEG reporting. J Clin Neurophysiol 2011;28:362–363.
5. Bagic AI, Barkley GL, Rose DF, Ebersole JS. American Clinical
Magnetoencephalography Society Clinical Practice Guideline 4: qualiﬁcations of MEG-EEG personnel. J Clin Neurophysiol 2011;28:364–
365.
6. Bagic AI, Bowyer SM, Kirsch HE, Funke ME, Burgess RC. American
Clinical MEG Society (ACMEGS) Position Statement #2: the value of
magnetoencephalography (MEG)/magnetic source imaging in noninvasive presurgical mapping of eloquent cortices of patients preparing for
surgical interventions. J Clin Neurophysiol 2017;34:189–195.

Journal of Clinical Neurophysiology Volume 37, Number 6, November 2020

clinicalneurophys.com

Copyright © by the American Clinical Neurophysiology Society. Unauthorized reproduction of this article is prohibited.

A. Zillgitt, et al.

A Review of Visual Evoked Fields

7. Papanicolaou AC. Clinical Magnetoencephalography and Magnetic Source
Imaging. 1st ed. New York: Cambridge University Press, 2009.
8. Barkley GL, Baumgartner C. MEG and EEG in epilepsy. J Clin
Neurophysiol 2003;20:163–178.
9. Knowlton RC, Shih J. Magnetoencephalography in epilepsy. Epilepsia
2004;45(suppl 4):61–71.
10. Ebersole JS, Ebersole SM. Combining MEG and EEG source modeling
in epilepsy evaluations. J Clin Neurophysiol 2010;27:360–371.
11. Flores LP. Occipital lobe morphological anatomy: anatomical and
surgical aspects. Arq Neuropsiquiatr 2002;60:566.
12. Bowyer SM, Mason K, Tepley N, Smith B, Barkley GL. Magnetoencephalographic validation parameters for clinical evaluation
of interictal epileptic activity. J Clin Neuorphysiol 2003;20:87–
93.
13. Cohen D. Magnetoencephalography: evidence of magnetic ﬁelds produced by alpha rhythm currents. Science 1968;161:784–786.
14. Cohen D. Magnetoencephalography: detection of the brain’s electrical
activity with a superconducting magnetometer. Science 1972;175:664–
666.
15. Brenner D, Williamson SJ, Kaufman L. Visually evoked magnetic ﬁelds
of the human brain. Science 1975;190:480–482.
16. Nakasato N, Seki K, Fujita S, et al. Clinical application of visual evoked
ﬁelds using an MRI-linked whole head MEG system. Front Med Biol
Eng 1996;7:275–283.
17. Seki K, Nakasato N, Fujita S et al. Neuromagnetic evidence that the
P100 component of the pattern reversal visual evoked response
originates in the bottom of the calcarine ﬁssure. Electrocencephalogr
Clin Neurophysiol 1996;100:436–442.
18. Harding GF, Janday B, Armstrong RA. Topographic mapping and
source localization of the pattern reversal visual evoked magnetic
response. Brain Topogr 1991;4:47–55.
19. Ikeda H, Nishijo H, Miyamoto K, et al. Generators of visual evoked
potentials investigated by dipole tracing in the human occipital cortex.
Neuroscience 1998;84:723–739.
20. Shigeto H, Tobimatsu S, Yamamoto T, Kobayashi T, Kato M. Visual
evoked cortical magnetic responses to checkerboard pattern reversal
stimulation: a study on the neural generators of N75, P100 and N145.
J Neurol Sci 1998;156:186–194.

clinicalneurophys.com

21. Matsumoto R, Ikeda A, Nagamine T, et al. Subregions of human MT
complex revealed by comparative MEG and direct electrocorticographic
recordings. Clin Neurophysiol 2004;115:2056–2065.
22. Grover KM, Bowyer SM, Rock J et al. Retrospective review of MEG
visual evoked hemiﬁeld responses prior to resection of temporo-parietooccipital lesions. J Neurooncol 2006;77:161–166.
23. Pang EW, Chu BH, Otsubo H. Occipital lobe lesions result in
a displacement of magnetoencephalography visual evoked ﬁeld dipoles.
J Clin Neurophysiol 2014;31:456–461.
24. Aoyama H, Kamada K, Shirato H, et al. Integration of functional brain
information into stereotactic irradiation treatment planning using magnetoencephalography and magnetic resonance axonography. Int J Radiat
Oncol Biol Phys 2004;58:1177–1183.
25. Inoue T, Fujimura M, Kumabe T. Combined three-dimensional anisotropy contrast imaging and magnetoencephalography guidance to preserve visual function in a patient with an occipital lobe tumor. Minim
Invasive Neurosurg 2004;47:249–252.
26. Bagic AI. Disparities in clinical magnetoencephalography practice in the
United States: a survey-based appraisal. J Clin Neurophysiol 2011;28:341–
347.
27. Fujisawa Y, Minato T, Uemura JI, et al. Association between changes in
visual evoked magnetic ﬁelds and non-motor features in Parkinson’s
disease. Nagoya J Med Sci 2017;79:147–155.
28. Mizuno K, Tsuji T, Rossetti Y, et al. Early visual processing is affected
by clinical subtype in patients with unilateral spatial neglect: a magnetoencephalography study. Front Hum Neurosci 2013;7:432.
29. Wilson TW, Fox HS, Robertson KR, et al. Abnormal MEG oscillatory
activity during visual processing in the prefrontal cortices and frontal
eye-ﬁelds of the aging HIV brain. PLoS One 2013;8:e66241.
30. Barratt EL, Tewarie PK, Clarke MA, et al. Abnormal task driven neural
oscillation in multiple sclerosis: a visuomotor MEG study. Hum Brain
Mapp 2017;38:2441–2453.
31. Tanaka K, Araki T, Kuriki S, et al. Steady-state visually evoked ﬁelds
(SSVEF) associated with affective emotions. Conf Proc IEEE Eng Med
Biol Soc 2013;2013:4422–4425.
32. Lobier M, Palva JM, Palva S. High-alpha band synchronization across
frontal, parietal and visual cortex medicates behavioral and neuronal
effects of visuospatial attention. Neuroimage 2018;165:222–237.

Journal of Clinical Neurophysiology Volume 37, Number 6, November 2020

591

Copyright © by the American Clinical Neurophysiology Society. Unauthorized reproduction of this article is prohibited.

